Testing a new drug for stubborn high cholesterol
Treatments studied
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This trial tests a new medication (QLC7401) for people with high cholesterol that is not well controlled by their current treatment. It aims to see if the drug can help lower LDL-C (bad cholesterol) levels and reduce the risk of heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- Your LDL (bad) cholesterol must be at least 1.8 mmol/L if you have heart/vessel disease, or at least 2.6 mmol/L if you don't.
- Your triglycerides (a type of fat) must be 4.5 mmol/L (400 mg/dL) or lower.
- You must have been on the same cholesterol-lowering medication (like a statin) for at least 4 weeks before starting.
- You cannot have had a recent heart attack, stroke, or serious heart failure, or have uncontrolled high blood pressure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug, QLC7401, for people with high LDL cholesterol that hasn't lowered enough with current treatments. It aims to see if the drug can help reduce cholesterol levels in patients who are already on stable cholesterol medication.
This trial tests if a new drug, QLC7401, can lower cholesterol in people with high cholesterol who are not on other cholesterol medicines. It may be an option if you have low or medium risk of heart disease and no history of heart problems.
This study tests how a new drug moves through the body and affects cholesterol levels. It is for people with moderately high cholesterol who are otherwise healthy.
This trial tests an experimental medication called QLC7401 for people with a genetic condition that causes very high cholesterol. It aims to lower cholesterol levels safely and may be an option for those who need better control.
This trial tests a new medication called SHR-1918 for people with high cholesterol who are already on statins. The goal is to see if it can further lower cholesterol and improve health.
This study tests an experimental drug called HRS-1301 to see if it safely lowers LDL ("bad") cholesterol in people with high cholesterol. It is for adults who either already have artery disease or are at higher risk for it.
Hear when a new Primary Hypercholesterolemia or Mixed Hyperlipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.